| 6509 | Humans |
| 3576 | Male |
| 3402 | Female |
| 3357 | Indium Radioisotopes (diagnostic use) |
| 2874 | Animals |
| 2287 | Middle Aged |
| 2127 | Adult |
| 1826 | Indium (diagnostic use) |
| 1689 | Aged |
| 1374 | Radioisotopes (diagnostic use) |
| 1170 | Mice |
| 1010 | Indium (chemistry) |
| 908 | Tissue Distribution |
| 792 | Antibodies, Monoclonal (diagnostic use) |
| 744 | Indium |
| 714 | Time Factors |
| 695 | Rats |
| 669 | Radiopharmaceuticals (diagnostic use) |
| 633 | Technetium (diagnostic use) |
| 633 | Pentetic Acid (diagnostic use) |
| 623 | Radionuclide Imaging |
| 617 | Leukocytes |
| 592 | Radioisotopes |
| 574 | Sensitivity and Specificity |
| 494 | Adolescent |
| 487 | Oxyquinoline (analogs & derivatives) |
| 481 | Indium Radioisotopes (pharmacokinetics) |
| 468 | Tin Compounds (chemistry) |
| 465 | Octreotide (diagnostic use) |
| 447 | Oxyquinoline (diagnostic use) |
| 430 | Surface Properties |
| 429 | Organometallic Compounds (diagnostic use) |
| 427 | Octreotide (analogs & derivatives) |
| 424 | Iodine Radioisotopes (diagnostic use) |
| 419 | Indium Radioisotopes |
| 408 | Tomography, Emission-Computed, Single-Photon |
| 407 | Pentetic Acid (analogs & derivatives) |
| 395 | Electrodes |
| 386 | Mice, Nude |
| 380 | Tomography, X-Ray Computed |
| 379 | Somatostatin (analogs & derivatives) |
| 360 | Dogs |
| 346 | Equipment Design |
| 342 | Aged, 80 and over |
| 331 | Isotope Labeling |
| 326 | Particle Size |
| 316 | Kinetics |
| 302 | Somatostatin (diagnostic use) |
| 289 | Child |
| 288 | Rabbits |
| 285 | Radiopharmaceuticals (pharmacokinetics) |
| 284 | Materials Testing |
| 283 | Blood Platelets |
| 279 | Methods |
| 276 | Radioimmunodetection |
| 270 | Gallium (chemistry) |
| 270 | Catalysis |
| 262 | Cell Line, Tumor |
| 260 | Molecular Structure |
| 255 | Neoplasm Transplantation |
| 250 | Mice, Inbred BALB C |
| 249 | Reproducibility of Results |
| 248 | Diagnosis, Differential |
| 247 | Blood Platelets (physiology) |
| 246 | Equipment Failure Analysis |
| 244 | Gallium Radioisotopes (diagnostic use) |
| 240 | Organometallic Compounds |
| 240 | Indium Radioisotopes (therapeutic use) |
| 237 | Receptors, Somatostatin (analysis) |
| 237 | Nanostructures (chemistry) |
| 226 | Antibodies, Monoclonal (pharmacokinetics) |
| 223 | Pregnancy |
| 223 | Microscopy, Electron, Scanning |
| 222 | Cell Survival |
| 220 | Isotope Labeling (methods) |
| 212 | Prospective Studies |
| 205 | Technetium |
| 204 | Semiconductors |
| 198 | Arsenicals (chemistry) |
| 196 | Liver (metabolism) |
| 195 | Magnetic Resonance Imaging |
| 189 | Temperature |
| 188 | Indium (metabolism) |
| 187 | Oxidation-Reduction |
| 186 | Hydroxyquinolines (diagnostic use) |
| 186 | Antibodies, Monoclonal (therapeutic use) |
| 185 | Transplantation, Heterologous |
| 183 | Electrochemistry |
| 181 | Neoplasms (radionuclide imaging) |
| 181 | Follow-Up Studies |
| 179 | Quantum Dots |
| 172 | Radiation Dosage |
| 172 | Pentetic Acid (pharmacokinetics) |
| 171 | Nanotechnology (methods) |
| 170 | Heart (radionuclide imaging) |
| 169 | Evaluation Studies as Topic |
| 166 | Retrospective Studies |
| 166 | Myosins (immunology) |
| 163 | Light |
| 162 | Receptors, Somatostatin (metabolism) |
| 161 | Cells, Cultured |
| 160 | Child, Preschool |
| 159 | Hydrogen-Ion Concentration |
| 159 | Carcinoid Tumor (radionuclide imaging) |
| 157 | Tumor Cells, Cultured |
| 156 | Blood Vessel Prosthesis |
| 155 | Indium Radioisotopes (chemistry) |
| 154 | Molecular Conformation |
| 153 | Octreotide (therapeutic use) |
| 152 | Carcinoembryonic Antigen (immunology) |
| 151 | Osteomyelitis (radionuclide imaging) |
| 151 | Liver (radionuclide imaging) |
| 149 | Crystallization (methods) |
| 147 | Predictive Value of Tests |
| 147 | Nanostructures (ultrastructure) |
| 146 | Lung (radionuclide imaging) |
| 146 | Abscess (radionuclide imaging) |
| 144 | Treatment Outcome |
| 144 | Organotechnetium Compounds (diagnostic use) |
| 144 | Neoplasm Metastasis |
| 141 | Liver Neoplasms (secondary) |
| 138 | Nanoparticles (chemistry) |
| 138 | Myocardial Infarction (radionuclide imaging) |
| 138 | Injections, Intravenous |
| 138 | Antibodies, Monoclonal (immunology) |
| 137 | Half-Life |
| 136 | Organometallic Compounds (chemistry) |
| 135 | Radionuclide Imaging (methods) |
| 135 | Pancreatic Neoplasms (radionuclide imaging) |
| 135 | Lung Neoplasms (radionuclide imaging) |
| 134 | Stereoisomerism |
| 134 | Radiopharmaceuticals (therapeutic use) |
| 132 | Polymers (chemistry) |
| 131 | Neuroendocrine Tumors (radionuclide imaging) |
| 131 | Gold (chemistry) |
| 130 | Tomography, Emission-Computed, Single-Photon (methods) |
| 130 | Liver Neoplasms (radionuclide imaging) |
| 129 | False Positive Reactions |
| 128 | Radioimmunotherapy |
| 126 | Tomography, Emission-Computed |
| 126 | Metabolic Clearance Rate |
| 125 | Electric Conductivity |
| 124 | Infant |
| 123 | Disease Models, Animal |
| 121 | Yttrium Radioisotopes (therapeutic use) |
| 119 | Neoplasm Recurrence, Local (radionuclide imaging) |
| 119 | Models, Molecular |
| 119 | Electrochemistry (methods) |
| 119 | Biosensing Techniques (methods) |
| 118 | Octreotide (pharmacokinetics) |
| 116 | Swine |
| 116 | Metal Nanoparticles (chemistry) |
| 114 | Rats, Inbred Strains |
| 114 | Models, Chemical |
| 113 | Rats, Wistar |
| 111 | Phosphines (chemistry) |
| 111 | Indium Radioisotopes (administration & dosage) |
| 111 | Electrons |
| 109 | Platelet Count |
| 108 | Computer Simulation |
| 108 | Cell Line |
| 107 | Protein Binding |
| 107 | Neoplasm Staging |
| 107 | Bone Marrow (radionuclide imaging) |
| 106 | Blood Platelets (radionuclide imaging) |
| 105 | Polytetrafluoroethylene |
| 105 | Kidney (metabolism) |
| 105 | Antibodies, Monoclonal (metabolism) |
| 104 | Prostatic Neoplasms (radionuclide imaging) |
| 103 | X-Ray Diffraction |
| 103 | Thrombosis (radionuclide imaging) |
| 103 | Copper (chemistry) |
| 103 | Acute Disease |
| 102 | Technetium Tc 99m Medronate (diagnostic use) |
| 102 | Indium (analysis) |
| 102 | Autoradiography |
| 101 | Prognosis |
| 100 | Inflammation (radionuclide imaging) |
| 99 | Thyroid Neoplasms (radionuclide imaging) |
| 99 | Colorectal Neoplasms (radionuclide imaging) |
| 99 | Chronic Disease |
| 99 | Cell Movement |
| 98 | Blood Platelets (drug effects) |
| 97 | Spleen (radionuclide imaging) |
| 97 | Leukocytes (radionuclide imaging) |
| 97 | Immunohistochemistry |
| 97 | Adenocarcinoma (radionuclide imaging) |
| 96 | Ligands |
| 96 | Indium Radioisotopes (metabolism) |
| 96 | Drug Stability |
| 96 | Biosensing Techniques (instrumentation) |
| 95 | Macromolecular Substances (chemistry) |
| 95 | Lung (metabolism) |
| 95 | Breast Neoplasms (radionuclide imaging) |
| 94 | Indium (toxicity) |
| 94 | Colloids |
| 93 | Solar Energy |
| 92 | Nanotechnology (instrumentation) |
| 92 | Infection (radionuclide imaging) |
| 92 | Blood Platelets (metabolism) |
| 92 | Antibodies, Monoclonal |
| 91 | Heterocyclic Compounds, 1-Ring (chemistry) |
| 91 | Colonic Neoplasms (radionuclide imaging) |
| 89 | Technetium Tc 99m Sulfur Colloid (diagnostic use) |
| 89 | Spleen (metabolism) |
| 89 | Graft Rejection |
| 88 | Radioimmunodetection (methods) |
| 88 | Melanoma (radionuclide imaging) |
| 87 | Pentetic Acid (chemistry) |
| 87 | Nanotubes (chemistry) |
| 87 | Antibodies, Monoclonal (administration & dosage) |
| 86 | Radioimmunotherapy (methods) |
| 86 | Platelet Aggregation |
| 86 | Immunoglobulin G (diagnostic use) |
| 85 | Tropolone (diagnostic use) |
| 85 | Rats, Sprague-Dawley |
| 85 | Radiopharmaceuticals (chemistry) |
| 85 | Pentetic Acid |
| 85 | Granulocytes |
| 84 | Organometallic Compounds (pharmacokinetics) |
| 84 | Microscopy, Atomic Force |
| 84 | Dose-Response Relationship, Drug |
| 83 | Myocardium (pathology) |
| 83 | Membranes, Artificial |
| 83 | Erythrocytes |
| 83 | Chromatography, High Pressure Liquid |
| 83 | Chelating Agents (chemistry) |
| 82 | Technetium Tc 99m Exametazime |
| 82 | Ovarian Neoplasms (radionuclide imaging) |
| 82 | Indium (administration & dosage) |
| 82 | Adsorption |
| 81 | Oxides (chemistry) |
| 81 | Biopsy |
| 81 | Amino Acid Sequence |
| 80 | Positron-Emission Tomography |
| 80 | Pentetic Acid (metabolism) |
| 80 | Bleomycin (diagnostic use) |
| 79 | Radiotherapy Dosage |
| 79 | Models, Biological |
| 79 | Mice, Inbred C57BL |
| 78 | Platelet Aggregation (drug effects) |
| 78 | Oximes (diagnostic use) |
| 78 | Gastric Emptying |
| 78 | False Negative Reactions |
| 77 | Tin Compounds |
| 77 | Regional Blood Flow |
| 77 | Liver Neoplasms (diagnosis) |
| 77 | Kidney (radionuclide imaging) |
| 77 | Crohn Disease (radionuclide imaging) |
| 76 | Electrochemistry (instrumentation) |
| 75 | Brain Neoplasms (diagnosis) |
| 75 | Antigens, Neoplasm (immunology) |
| 74 | Molecular Sequence Data |
| 74 | Lymphatic Metastasis |
| 74 | Iodine Radioisotopes |
| 73 | Hot Temperature |
| 72 | Nanowires (chemistry) |
| 72 | Microspheres |
| 72 | Cell Adhesion |
| 71 | Recurrence |
| 71 | Colon (radionuclide imaging) |
| 71 | Cell Survival (drug effects) |
| 70 | Water (chemistry) |
| 70 | Gamma Cameras |
| 70 | Chromium Radioisotopes (diagnostic use) |
| 70 | Bone Neoplasms (radionuclide imaging) |
| 69 | Radiometry |
| 69 | Indium (blood) |
| 69 | Crystallography, X-Ray |
| 69 | Bone and Bones (radionuclide imaging) |
| 68 | Thrombophlebitis (radionuclide imaging) |
| 68 | Silicon (chemistry) |
| 68 | Radioisotopes (metabolism) |
| 67 | Zinc Oxide (chemistry) |
| 67 | Magnetic Resonance Spectroscopy |
| 67 | Electrochemical Techniques |
| 66 | Antibodies, Monoclonal (chemistry) |
| 65 | Tropolone (analogs & derivatives) |
| 65 | Thrombosis (etiology) |
| 65 | Silver (chemistry) |
| 65 | Microelectrodes |
| 65 | Combined Modality Therapy |
| 65 | Cattle |
| 65 | Breast Neoplasms (metabolism) |
| 64 | Placenta (blood supply) |
| 64 | Microscopy, Electron, Transmission |
| 63 | Radiopharmaceuticals (administration & dosage) |
| 63 | Radioisotope Dilution Technique |
| 63 | Postoperative Complications (radionuclide imaging) |
| 63 | Organ Specificity |
| 63 | Neoplasms (metabolism) |
| 63 | Lymph Nodes (radionuclide imaging) |
| 63 | Liver Diseases (diagnosis) |
| 63 | Indicators and Reagents |
| 63 | Crystallization |
| 62 | Ultrasonography |
| 62 | Sulfides (chemistry) |
| 61 | Solutions |
| 61 | Radiopharmaceuticals (chemical synthesis) |
| 61 | Polyethylene Terephthalates |
| 61 | Placenta |
| 61 | Oligopeptides (diagnostic use) |
| 61 | Neoplasms (diagnosis) |
| 61 | Iodine Radioisotopes (therapeutic use) |
| 61 | Image Processing, Computer-Assisted |
| 60 | Titanium (chemistry) |
| 60 | Reference Values |
| 60 | Rats, Inbred Lew |
| 60 | Papio |
| 60 | Neutrophils (physiology) |
| 60 | Leukocyte Count |
| 60 | Citrates (diagnostic use) |
| 60 | Bone Neoplasms (secondary) |
| 59 | Transferrin (diagnostic use) |
| 59 | Scattering, Radiation |
| 59 | Peptides (chemistry) |
| 59 | Organometallic Compounds (chemical synthesis) |
| 59 | Lasers |
| 59 | Indium (pharmacology) |
| 59 | Dose-Response Relationship, Radiation |
| 59 | Bacterial Infections (radionuclide imaging) |
| 58 | Neoplasms (radiotherapy) |
| 58 | Microscopy, Electron |
| 58 | Luminescence |
| 57 | Yttrium Radioisotopes (pharmacokinetics) |
| 57 | Thallium Radioisotopes (diagnostic use) |
| 57 | Stomach (radionuclide imaging) |
| 57 | Prostatic Neoplasms (pathology) |
| 57 | Nanotubes (ultrastructure) |
| 57 | Cyclization |
| 57 | Algorithms |
| 56 | Neoplasms, Experimental (metabolism) |
| 56 | Kidney Transplantation |
| 56 | Iodine Radioisotopes (pharmacokinetics) |
| 56 | Clinical Trials as Topic |
| 55 | Pulmonary Circulation |
| 55 | Indium (radiation effects) |
| 55 | Immunoglobulin Fab Fragments (diagnostic use) |
| 55 | Antineoplastic Agents (therapeutic use) |
| 54 | Transferrin (metabolism) |
| 54 | Spectrophotometry, Ultraviolet |
| 54 | Neoplasms, Experimental (radionuclide imaging) |
| 54 | Gastrointestinal Neoplasms (radionuclide imaging) |
| 54 | Electric Power Supplies |
| 54 | Brain Neoplasms (radionuclide imaging) |
| 52 | Somatostatin (therapeutic use) |
| 52 | Solubility |
| 52 | Lung (pathology) |
| 52 | Isotopes |
| 52 | Heart Transplantation |
| 52 | Gallium |
| 52 | Feasibility Studies |
| 52 | Cricetinae |
| 52 | Breast Neoplasms (pathology) |
| 52 | Blood Platelets (cytology) |
| 51 | Serum Albumin (diagnostic use) |
| 51 | Photochemistry (methods) |
| 51 | Necrosis |
| 51 | Inflammatory Bowel Diseases (radionuclide imaging) |
| 51 | Guinea Pigs |
| 51 | Electron Transport |
| 51 | Antibodies, Monoclonal, Humanized |
| 51 | Abdomen (radionuclide imaging) |
| 50 | Zinc (chemistry) |
| 50 | Radioisotopes (therapeutic use) |
| 50 | Placenta Previa (diagnosis) |
| 50 | Photons |
| 50 | Optics and Photonics |
| 50 | Lighting (instrumentation) |
| 50 | Immunoconjugates (pharmacokinetics) |
| 49 | Quantum Theory |
| 49 | Palladium (chemistry) |
| 49 | Infant, Newborn |
| 49 | Glass (chemistry) |
| 49 | Citric Acid |
| 49 | Binding, Competitive |
| 48 | Xenograft Model Antitumor Assays |
| 48 | Transistors, Electronic |
| 48 | Somatostatin (pharmacokinetics) |
| 48 | Serum Albumin, Radio-Iodinated (diagnostic use) |
| 48 | Positron-Emission Tomography (methods) |
| 48 | Nanotubes, Carbon (chemistry) |
| 48 | Immunoglobulin Fab Fragments (immunology) |
| 48 | Blood Vessel Prosthesis (adverse effects) |
| 48 | Analysis of Variance |
| 47 | Whole-Body Counting |
| 47 | Tin |
| 47 | Thrombosis (prevention & control) |
| 47 | Polystyrenes (chemistry) |
| 47 | Mice, SCID |
| 47 | Gastric Emptying (physiology) |
| 47 | Fluorodeoxyglucose F18 (diagnostic use) |
| 47 | Drug Carriers |
| 47 | Colitis, Ulcerative (radionuclide imaging) |
| 47 | Carcinoma, Medullary (radionuclide imaging) |
| 47 | Cadmium Compounds (chemistry) |
| 46 | Transplantation, Homologous |
| 46 | Sheep |
| 46 | Models, Theoretical |
| 46 | Aldehydes (chemistry) |
| 45 | Tomography, X-Ray Computed (methods) |
| 45 | Tomography, Emission-Computed (methods) |
| 45 | Technetium Tc 99m Aggregated Albumin (diagnostic use) |
| 45 | Splenectomy |
| 45 | Spectroscopy, Fourier Transform Infrared |
| 45 | Pilot Projects |
| 45 | Myocarditis (radionuclide imaging) |
| 45 | Metals (chemistry) |
| 45 | Lymphatic Metastasis (radionuclide imaging) |
| 45 | Immunoglobulin G (metabolism) |
| 45 | Gastrointestinal Transit |
| 45 | Echocardiography |
| 45 | Drug Delivery Systems |
| 45 | Colonic Neoplasms (metabolism) |
| 45 | Chelating Agents (pharmacokinetics) |
| 45 | Carcinoid Tumor (secondary) |
| 45 | Biological Transport |
| 44 | Yttrium Radioisotopes (diagnostic use) |
| 44 | Phantoms, Imaging |
| 44 | Mice, Inbred Strains |
| 44 | Indium Radioisotopes (blood) |
| 44 | Gamma Rays |
| 44 | Femoral Artery (surgery) |
| 44 | Electrocardiography |
| 44 | Electric Impedance |
| 44 | Carcinoma (radionuclide imaging) |
| 44 | Biosensing Techniques |
| 44 | Antineoplastic Agents, Hormonal (therapeutic use) |
| 44 | Antibody Specificity |
| 43 | Uterus (blood supply) |
| 43 | Rectal Neoplasms (radionuclide imaging) |
| 43 | Pentetic Acid (therapeutic use) |
| 43 | Pentetic Acid (administration & dosage) |
| 43 | Pancreatic Neoplasms (pathology) |
| 43 | Pancreatic Neoplasms (metabolism) |
| 43 | Pancreatic Neoplasms (diagnosis) |
| 43 | Neuroendocrine Tumors (radiotherapy) |
| 43 | Lymphoma (radionuclide imaging) |
| 43 | Lymphocytes (immunology) |
| 43 | Graphite (chemistry) |
| 43 | Coronary Circulation |
| 43 | Chelating Agents |
| 43 | Bone Marrow (metabolism) |
| 43 | Binding Sites |
| 43 | Antibodies, Monoclonal (adverse effects) |
| 42 | Zinc Compounds (chemistry) |
| 42 | Serum Albumin, Radio-Iodinated |
| 42 | Receptor, erbB-2 (metabolism) |
| 42 | Radiopharmaceuticals (metabolism) |
| 42 | Pulmonary Embolism (radionuclide imaging) |
| 42 | Perfusion |
| 42 | Neutrophils |
| 42 | Myocardium (metabolism) |
| 42 | Lung Diseases (diagnosis) |
| 42 | Immunoglobulin Fab Fragments |
| 42 | Contrast Media |
| 42 | Cell Separation |
| 42 | Angiography |
| 42 | Administration, Oral |
| 42 | Abscess (diagnosis) |
| 42 | Abdomen |
| 41 | Tin (chemistry) |
| 41 | Physicochemical Phenomena |
| 41 | Infusions, Intravenous |
| 41 | Computer-Aided Design |
| 41 | Carbon (chemistry) |
| 41 | Aluminum (chemistry) |
| 40 | Platelet Adhesiveness |
| 40 | Pituitary Neoplasms (radionuclide imaging) |
| 40 | Phagocytosis |
| 40 | Lung (blood supply) |
| 40 | Liver |
| 40 | Food |
| 40 | Electrochemical Techniques (methods) |
| 40 | Edetic Acid (diagnostic use) |
| 40 | Diagnostic Errors |
| 40 | Chelating Agents (diagnostic use) |
| 40 | Carcinoma, Small Cell (radionuclide imaging) |
| 40 | Aerosols |
| 39 | Thiophenes (chemistry) |
| 39 | Structure-Activity Relationship |
| 39 | Staining and Labeling |
| 39 | Spectrum Analysis |
| 39 | Silicon Dioxide (chemistry) |
| 39 | Refractometry (instrumentation) |
| 39 | Photochemistry |
| 39 | Octreotide (metabolism) |
| 39 | Mathematics |
| 39 | Lung (drug effects) |
| 39 | Indium (pharmacokinetics) |
| 39 | Hemodynamics |
| 39 | Enzymes, Immobilized (chemistry) |
| 39 | Endothelium, Vascular (cytology) |
| 39 | Chemistry, Physical |
| 39 | Cardiac Output |
| 39 | Carcinoembryonic Antigen (analysis) |
| 39 | Brain Diseases (diagnosis) |
| 39 | Antibodies, Monoclonal (pharmacology) |
| 39 | Adenocarcinoma (secondary) |
| 38 | Young Adult |
